European Conference on Allostery in Drug Discovery
Host Organization: Biomedical Research Foundation, Academy of Athens, Greece
Scientists-in-charge: Dr. Zoe Cournia Dates: 7-8 April 2025 ALLODD ESR Workshop 9-11 April 2025 European Conference on Allostery in Drug Discovery |
Confirmed speakers
Jean-Pierre Changeux
Honorary President, Department of Neuroscience Institute Pasteur, Paris, France Xavier Barril Global NCE Boehringer Ingelheim Pharma Petros Giastas Assistant Professor, Department of Biotechnology, Agricultural University of Athens, Greece Enrico Guarnera Scientific Associate Director Merck KGaA Healthcare, Germany Judith Günther Senior Researcher, Computational Design Bayer, Germany Simone Fulle Director, Protein Engineering, Computational Drug Design, Digital Science and Innovation Novo Nordisk, Denmark Babis Kalodimos Chair, Structural Biology Department Joseph Simone Endowed Chair in Basic Research St. Jude Children's Research Hospital, USA Dimitris Leonidas Professor, Department of Biochemistry and Biotechnology University of Thessaly, Greece Thanos Papakyriakou Senior Researcher, Institute of Biosciences & Applications NCSR Demokritos, Greece Anastassis Perrakis Professor, Utrecht University Division of Biochemistry, Netherlands Cancer Institute and Oncode Institute Yiorgo Skiniotis Endowed Chair and Founding Director, Center of Excellence for Structural Cell Biology St. Jude Children's Research Hospital, USA George Spyroulias Professor, Department of Pharmacy Unversity of Patras Efstratios Stratikos Associate Professor and Director, Laboratory of Biochemistry Department of Chemistry, National and Kapodistrian University of Athens, Greece Antoine Taly Researcher, Laboratoire de Biochimie Théorique CNRS and Université Paris Cité, France Marco de Vivo Associate Director, Computational Sciences Italian Institute of Technology, Italy Reto Walser Associate Director Astex Pharmaceuticals, UK |
Registration |
Program
The full program will be announced soon.
-
DAY 1
-
DAY 2
-
DAY 3
-
DAY 4
-
DAY 5
<
>
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
|